Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Medicinal Chemistry|May 17, 2023
Inside PD-1/PD-L1,2 with their inhibitorsNicolas Boisgerault, Philippe BertrandOncoimmunology|October 24, 2014
Trick and treat: Ambushing recurrent tumors before they get out of the doorNicolas Boisgerault, Richard G VileImmunotherapy|July 20, 2010
New perspectives in cancer virotherapy: bringing the immune system into playNicolas Boisgerault, Frédéric Tangy, Marc GregoireVirologie (Montrouge, France)|August 18, 2025
[Antitumor immuno-virotherapy with attenuated strains of measles virus]Jean-François Fonteneau, Nicolas Boisgerault, Frédéric TangyCancer Research|June 19, 2008
Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 responseAnne Gauvrit, Samantha Brandler, Carole Sapede-Peroz, et al.Molecular Cancer|March 25, 2021
Delivery of cancer therapies by synthetic and bio-inspired nanovectorsTina Briolay, Tacien Petithomme, Morgane Fouet, et al.Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell DeathTiphaine Delaunay, Carole Achard, Marc Grégoire, et al.Oncolytic Virotherapy|August 12, 2016
Oncolytic virotherapy for human malignant mesothelioma: recent advancesNicolas Boisgerault, Carole Achard, Tiphaine Delaunay, et al.Biological Research|June 13, 2012
Human dendritic cells sequentially matured with CD4(+) T cells as a secondary signal favor CTL and long-term T memory cell responsesThomas Simon, Séverine Tanguy-Royer, Pierre-Joseph Royer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2013
Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cellsJean-Baptiste Guillerme, Nicolas Boisgerault, David Roulois, et al.Pageof 4